Home › Teva and Takeda Agree to Commercialize Rasagiline for Parkinson's Disease Treatment in Japan
 

Keywords :   


Teva and Takeda Agree to Commercialize Rasagiline for Parkinson's Disease Treatment in Japan

2014-04-28 04:37:19| Biotech - Topix.net

Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement allowing Takeda to commercialize Teva's innovative treatment for Parkinson's disease, rasagiline* in Japan.

Tags: in japan agree treatment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11STEINBACH40
24.11 Sepua Crue F-170
24.11 SECRET
24.11CRAwith
24.1111/15)&&
24.11 8
24.11
24.11F2023 23
More »